# Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

> **NCT01703793** · PHASE2 · COMPLETED · sponsor: **Medicis Global Service Corporation** · enrollment: 240 (actual)

## Conditions studied

- Seborrheic Dermatitis

## Interventions

- **DRUG:** Test Product 49778
- **DRUG:** Test Product 10156
- **DRUG:** Vehicle (placebo)

## Key facts

- **NCT ID:** NCT01703793
- **Lead sponsor:** Medicis Global Service Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2013-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703793, "Safety and Efficacy Study in Subjects With Seborrheic Dermatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01703793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*